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Introduction - why uncertainty matters  
As if writing prophetically about the global Covid-19 pandemic, in 1984 Eddy 
suggested, “Uncertainty creeps into medical practice through every pore. Whether a 
physician is defining a disease, making a diagnosis, selecting a procedure, observing 
outcomes, assessing probabilities, assigning preferences, or putting it all together, he 
(or she) is walking on very slippery terrain” 1. Covid-19 has rapidly become a disease 
associated with unbridled uncertainty with its aetiology and management, for the 
healthcare systems and health professionals who provide care, and among its ultimate 
victims, patients and their families.  
 
Frustratingly, uncertainty is not a simple or easily defined concept and situations of 
uncertainty often result from several inter-related factors. It has has been 
characterised as an inadequate understanding, a sense of incomplete, ambiguous or 
unreliable information, and conflicting alternatives 2. In the current Covid-19 
pandemic, any given situation of uncertainty may be made up of several of these 
factors, but equally, there are many forms of uncertainty 3. Irrespective of its origin, 
we know uncertainty matters because when suppressed and ignored, consciously and 
subconsciously, it has potential to negatively impact on patients, their family, at a 
profoundly emotional level 4. It also affects health professionals and it has been 
argued their tolerance of uncertainty can affect levels of investigation, patient safety, 
as well as healthcare resource use 5. The authors of this commentary - an ITU 
physician, a palliative care physician and two social scientists - critically synthesise 
evidence from this grey area of uncertainty associated with Covid-19 and argue it is 
inescapable. In the face of the global proliferation of this disease and sense of 
urgency, they unite to consider how, in an area that is neither black nor white, 
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practical solutions that can be harnessed now, not to ‘outsmart’ uncertainty, but to 
acknowledge its presence and where possible, to work more effectively and 
efficiently alongside it to improve patient and family care at a critical moment in their 
lives (Tables 1 and 2).  
 
Covid-19: Known unknowns and unknown unknowns 
At the time of writing, there are over 3.6 million confirmed cases of Covid-19 across 
187 countries/world regions, of whom more than 250,000 have now died 6. Despite 
these figures, our understanding of the disease is still very much in its infancy. 
Confusion is present about the uncertain denominator making true mortality figures 
hard to quantify compounded by the unknown prevalence of asymptomatic infection. 
Moreover, in many countries accurate testing equipment is inadequate. 
 
We currently lack a sophisticated understanding of Covid-19 disease process and 
particularly why some individuals and groups are more affected than others. Those 
severely affected by the disease are typically over-represented by those who are 
elderly, those with multiple morbidities and are frail, and mysteriously those from 
certain ethnic groups. However, the uncertainty of Covid-19 has resulted in 
catastrophic consequences, regardless of these contributory factors.  
 
As yet, there are no effective therapies for Covid-19 and those available are 
essentially supportive or palliative. Treatments currently being tested include 
antimalarial, antiviral, immunomodulator and steroid drugs, often adaptive in design 
with multiple intervention arms, reducing the chance of patients being randomised to 
just placebo. However, the trade-off is potential harms may be present associated with 
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multiple-drug interactions. For example, the American College of Cardiology has 
issued a warning statement of the potential harm and higher risk mortality when 
combining hydroxycholoquine with azithromycin 7.  
 
Vagueness extends to an incomplete understanding of patient outcomes. Until 
recently, mortality figures typically included only hospital deaths but not community 
deaths, including care homes, confusing the true incidence of the disease. For those 
with severe enough symptoms to be admitted to hospital, their routes tend to take one 
of two roads, both of which may lead to a chasm. Those with the best prospects of 
survival may end up in ICU whereas those with more underlying problems may be 
sent to an acute medical unit where they may succumb or survive. Specifically, 
outcomes data for intensive care units (ICU) patients is biased towards those with 
shorter length of stay because they are still receiving care at the time of analysis, an 
unavoidable occurrence during a  constantly changing pandemic 8. At present, no 
information is available on longer-term survival or non-mortality related outcomes, 
including quality of life influenced by physical disability, psychosocial morbidity and 
new dependency needs 9. 
 
In turbulent Covid-19 waters, health systems are ships that require navigation  
The Covid-19 pandemic is presenting unprecedented uncertainty in terms of how 
health care systems should respond 10 and exists at the level of structures and 
processes of care. Specifically, structural uncertainty relates to physical environments 
of care, medical equipment and consumables. Services are trying to extrapolate from 
emerging and incomplete data to guide levels of resources required by patients, 
confused by additional uncertainty as to whether subsequent peaks in Covid-19 may 
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be expected. Hospital beds, ICUs and their associated equipment, including 
ventilators and infusion pumps are vital for the treatment of patients with a severe 
illness. However, previously untested models have been developed to identify that 
need.  
 
At the most mundane level uncertainty includes basic hospital resources, medication 
and the highly publicised provision of personal protective equipment (PPE). Not 
knowing also extends to the location of care. For example, there is evidence that 
whilst the number hospitals beds devoted to Covid-19 have been reducing, there have 
been unpredicted increases in the level of care provided by nursing homes to frail, 
elderly people with complex needs, against a backdrop of limited staff and resources. 
 
Moving from structures to processes of care, there is considerable uncertainty 
concerning how to effectively process and manage patients who have tested positive 
to Covid-19 and those who have not, particularly if they present in emergency 
departments, a concern as the Covid-19 nasopharyngeal swab has a relatively high 
false-negative rate 11. If patients are falsely screened-negative they may be sent to a 
“clean ward” environment where they are potentially subjecting other patients and 
health professionals to risk. Conversely, if based on symptoms they are assumed 
positive and then located onto a “dirty ward” but subsequently turn out negative, then 
these patients are in-turn put at risk, particularly if they are already vulnerable. 
The peak of this pandemic may stretch systems and the decisions required to identify 
which Covid-19 patients who are most likely to benefit from escalating care 
(including to ICU). These judgments are beset with health process-related 
uncertainties. It is here that questions should be asked whether decision support aids 
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in line with the best available evidence. The Covid-19: Rapid Guidance for Critical 
Care developed by NICE emphasises choices be based on the “likelihood that a 
person will recover . . . to an outcome that is acceptable to them.” 12. However, from 
what we do know, considerable prognostic uncertainty is present 13. Where possible, 
clinicians should attempt to ascertain patients’ wishes and values regarding the 
escalation of care, particularly those who exhibit signs of impending or established 
organ failure. This should be factored into whether or not an escalation of care to an 
ICU is appropriate, is in their best interests and acceptable to them 14. However, in a 
pandemic scenario, it may be practically difficult to engage in lengthy conversations 
with acutely unwell patients. In addition, under pandemic conditions, where the 
availability of resources remains in doubt, it may be much harder to argue “all 
patients be treated without discrimination because everyone is of equal value” 15 with 
emphasis on their autonomy. Here, the concept of utilitarianism governing how 
health systems operate under stress may override this. Decisions to admit might also 
be influenced by health professionals’ implicit cognitive biases  16 to compensate for 
health system uncertainties regarding ICU bed availability.  
 
Insert table 1 here 
 
People at the epicentre of uncertainty – health professionals, patients and their 
families  
In the face of uncertainty, health professionals may react variably where their training 
has deliberately focused them towards specialism. However, the trade-off is that there 
is less personal adaptability for cross-specialty cover, and confidence required in the 
current pandemic. As more health professionals deliver care outside their comfort 
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zones this has the potential to over-investigation, overtreatment, or its opposite, that 
may compromise patient safety 5. 
 
Health professionals who believe they are uncertain about how a patient’s condition 
may progress or respond to treatment might feel they have let patients and families 
down. Moreover, some might make clinical decisions they feel uncomfortable about, 
or disagree with. As a consequence, they may become candidates for ‘moral injury’ 
resulting in stress, depression and PTSD 17. Many patients cared for with Covid-19 
may be ‘ill enough to die’. In hospital settings and the absence of family members, 
health professionals may well be required to comfort these individuals but feel that 
they lack confidence and competence to do so to good effect, particularly when they 
are not normally exposed to ‘life and death’ situations in their usual practice. Doubt 
also extends beyond the patients health professionals care for. For example, they 
might be working in new ward environments where the stability and familiarity of a 
known clinical team are not present.  
 
Pre-pandemic times, the existence of an information mountain might have provided a 
myth of certainty for the wider public. Paradoxically, given the current Covid-19 
climate where we are exposed to an ‘infodemic’ of news from multiple sources with 
multiple, contradictory messages, certainty is now an illusion and anxiety is 
omnipresent. For those individuals with Covid-19 sick enough to be admitted to 
hospital, they may rapidly become isolated from families, especially where visiting 
restrictions are in force. Both parties may be anxious about this period of profound 
separation and when, or even if, they will be reunited, survive and if so, what it might 
look like. This echoes closely with Florence Nightingale’s concern for those in 
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vulnerable positions, “Apprehension, uncertainty, waiting, expectation, fear of 
surprise, do a patient more harm than any exertion. Remember he is face to face with 
his enemy all the time” (p53) 18. We know from qualitative studies of illnesses pre-
dating Covid-19 uncertainty can negatively impact on patients’ experiences and 
outcomes of care.  Where uncertainty about their situation is present, patients become 
preoccupied to such an extent that their sense-of-self is changed 19. Patients and their 
families often want to discuss their situation of uncertainty, however, this rarely 
happens 20.  
 
Patients may experience an environment of care alien to any previous hospital 
experience which may be profoundly disconcerting. The requirement of health 
professionals to wear PPE and the possible absence of continuity of health 
professionals caring for them has potential to amplify this and more so if they are 
already confused as a direct consequence of their illness or from other co-morbidities 
16.  
 
Before the Covid-19 pandemic, evidence suggests exploring patients’ wishes 
regarding ICU admission were uncommon. This is despite evidence of older patients’ 
decreased willingness to want burdensome therapy or to risk severe disability to avoid 
death 21. Patients therefore may need assistance to recognize possible ‘trade-offs’ 
among their values and to understand the relationship between what is important to 
them and their families and treatment preferences 22. 
 
If they are not able to obtain timely and accessible information and up-dates about 
loved-ones families might be in a state of heightened anxiety. Evidence from an 
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evaluation of a UK-developed intervention to serve patients whose situations were 
clinically uncertain and where there was a risk they may die during their hospital stay 
observed inconsistencies in information family members received with concomitant 
repercussions for satisfaction 20. Additionally, families may challenge health care 
decisions if they do not understand what is happening.  
 
Multiple barriers to a discussion of prognosis with patients with Covid-19 and their 
families may be present including lack of time, lack of expertise and a fear of taking 
away hope.  It is also possible health professionals may have overriding concerns not 
to share their uncertainty about a patient’s situation, believing patients and their 
families might question their competency or honesty, resulting in loss of professional 
confidence. Nevertheless, it has been shown appropriate expressions of uncertainty do 
indeed lead to stronger health professional-patient-family relationships.  
 
Insert table 2 here 
 
Conclusions  
In the current global pandemic of Covid-19, we can not eliminate uncertainty or the 
multitude of questions and doubts it creates. We argue a paradigm focused purely on 
its removal is futile. However, it can be managed far better than is done now to 
minimise its damage. The main business in hand must be for health professionals to 
support those patients and their families that occupy the ‘grey Covid-19 zone’ and 
build trusting empathetic relationships with them where uncertainty can be 
communicated in such a way that enables shared decision-making to reduce distress  
5. We must then learn from this pandemic and develop strategies to change 
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professional cultures that have thrived on developing antibodies to uncertainty and 
















All authors contributed equally 
 
 
1. Eddy DM. Variations in physician practice: the role of uncertainty. Health 
Aff (Millwood). 1984; 3: 74–89. 
2. Lipshitz R and Strauss O. Coping with uncertainty: A naturalistic decision-
making analysis. Organ Behav Hum Decis Process 1997; 69: 149–63. 
3. Kirkegaard P, Risor MB, Edwards A, Junge AG and Thomsen JL. Speaking 
of risk, managing uncertainty: decision-making about cholesterol-reducing 
treatment in general practice. Quality in primary care. 2012; 20: 245-52. 
4. Schwarze ML and Taylor LJ. Managing Uncertainty — Harnessing the 
Power of Scenario Planning. New England Journal of Medicine. 2017; 377: 206-8. 
 11 
5. Simpkin AL and Schwartzstein RM. Tolerating Uncertainty — The Next 
Medical Revolution? New England Journal of Medicine. 2016; 375: 1713-5. 
6. Johns Hopkins University & Medicine. COVID-19 Dashboard by the Center 
for Systems Science and Engineering (CSSE) at Johns Hopkins USA: Johns 
Hopkins University & Medicine, Coronavirus Resource Centre, 2020. 
7. Simpson TF, Kovacs RJ and Stecker EC. Ventricular arrhythmia risk due to 
hydroxychloroquine-azithromycin treatment for COVID-19. Cardiology 
Magazine. USA: American College of Cardiology, 2020. 
8. ICNARC. ICNARC report on COVID-19 in critical care. London, UK: 
Intensive Care National Audit & Research Centre (ICNARC), 2020, p. 17. 
9. Kress JP and Hall JB. ICU-acquired weakness and recovery from critical 
illness. The New England journal of medicine. 2014; 370: 1626-35. 
10. Abbasi K. COVID-19: fail to prepare, prepare to fail. Journal of the Royal 
Society of Medicine. 2020; 113: 131-. 
11. Yang Y, Yang M, Shen C, et al. Evaluating the accuracy of different 
respiratory specimens in the laboratory diagnosis and monitoring the viral 
shedding of 2019-nCoV infections. medRxiv. 2020: 2020.02.11.20021493. 
12. NICE. COVID 19: Rapid Guidance for Critical Care. National Institute for 
Health and Care Excellence 2020. 
13. Wynants L, Van Calster B, Bonten MMJ, et al. Prediction models for 
diagnosis and prognosis of covid-19 infection: systematic review and critical 
appraisal. BMJ. 2020; 369: m1328. 
14. Swiss Academy of Medical Sciences. COVID-19 pandemic: triage for 
intensive-care treatment under resource scarcity. Swiss medical weekly. 2020; 
150: w20229. 
15. Intensive Care Society. Clinical Guidance: Assessing whether COVID-19 
patients will benefit from critical care, and an objective approach to capacity 
challenges. London: Intensive Care Society 2020. 
16. Koffman J, Yorganci E, Yi D, et al. Managing uncertain recovery for 
patients nearing the end of life in hospital: a mixed-methods feasibility cluster 
randomised controlled trial of the AMBER care bundle. Trials. 2019; 20: 506. 
17. Cook D and Rocker G. Dying with Dignity in the Intensive Care Unit. New 
England Journal of Medicine. 2014; 370: 2506-14. 
18. Nightingale F. Notes on Nursing: What it is and What it is Not (1860). 
Appleton-Century: Digireads.com, 2010. 
19. Etkind SN, Bristowe K, Bailey K, Selman LE and Murtagh FE. How does 
uncertainty shape patient experience in advanced illness? A secondary analysis 
of qualitative data. Palliat Med. 2017; 31: 171-80. 
20. Bristowe K, Carey I, Hopper A, et al. Patient and carer experiences of 
clinical uncertainty and deterioration, in the face of limited reversibility: A 
comparative observational study of the AMBER care bundle. Palliat Med. 2015; 
29: 797-807. 
21. Philippart F, Vesin A, Bruel C, et al. The ETHICA study (part I): elderly's 
thoughts about intensive care unit admission for life-sustaining treatments. 
Intensive care medicine. 2013; 39: 1565-73. 
22. Bernacki R, Hutchings M, Vick J, et al. Development of the Serious Illness 
Care Program: a randomised controlled trial of a palliative care communication 
intervention. BMJ open. 2015; 5: e009032. 
 12 
23. Downar J and Seccareccia D. Palliating a pandemic: "all patients must be 
cared for". J Pain Symptom Manage. 2010; 39: 291-5. 
 13 
Table 1. Recommendations to address disease and health system uncertainties 
Disease uncertainties 
 
1 Develop and evolve guidance: Guidelines that can be modified for local use to inform 
important areas of clinical practice. These will be largely based on expert opinion 
initially but should be strengthened as evidence evolves.  
 
2. Count: Strategies to achieve a true denominator that more accurately reflects the extent 
of Covid-19 and allows more effective public health strategies to be deployed. 
 
3. Be promiscuous with lessons learned: Shared learning for health professionals via 
webinars and remote conference calls amongst a host of ‘experts’ or specialty leaders to 
inform best practice  
 
4. Build databases that can inform clinical care: Building knowledge from 
observational data by formulating datasets and databases to guide clinical practice with 
an awareness of limitations in data collected.  
 
5.  Robust clinical trials: Future effective therapies need to be urgently tested as part of 
clinical research trials. Areas currently under investigation: antivirals, steroids, 
immunomodulators, antimalarials, anticoagulation techniques and convalescent plasma 
transfusion. 
 
Health system uncertainties 
 
1. The four ‘S’: Four key domains are relevant to alleviate health system uncertainties 
associated with Covid-19: 
• Stuff: adequate supplies of equipment and medication e.g. opioids, anti-psychotics 
for delirium/nausea, antimuscarinic agents for secretions and syringe drivers, sub-
cutaneous butterflies for medication management;  
• Staff: health professionals with relevant expertise, confidence and competence;. 
preparation of protocols and guidelines that can be adapted locally for practice, 
presence of grief/bereavement counselors; 
• Space: maximizing and upgrading existing wards and beds/facilities to 
accommodate sicker patients and identifying non-clinical areas to be repurposed 
and transitioned promptly to respond to further Covid-19 “peaks”. 
• Systems: care plans in place for all patients that are shared electronically and 
seamlessly across care settings, including paramedics; liaison across provider 
networks to access knowledge for clinicians needing consultation support 23 
 
2. Prepare new systems more specific to pandemics: These may include reconfiguration 
of hospital sites and services into “clean” and “dirty” sites protecting patients and staff, 
allowing easier delineation between Covid-19 and non-Covid-19 related diseases; 
formation of triage and ‘reverse triage’ pathways based for those most likely to benefit 
in the event demand for medical services significantly outweigh supply, whilst ensuring 
fair access for everyone where possible. 
 
3. Learn from uncertainty: Uncertainty is a starting point for quality improvement. 
Uncertainty may expose preventable variation, erratic practices, safety errors or near 





Table 2. Recommendations to address health professional, patient and family 
uncertainty 
 
 Health professional uncertainties 
 
1. Admit uncertainty is not a failing: It has been suggested that appropriate expressions 
of uncertainty can lead to stronger health care professional-patient/family relationships, 
creating trust instead of unnecessary anxiety.  
 
2. All health professionals have an Achilles heel: Burnout, moral distress and moral 
injury have been identified as a significant issue among ICU and other health 
professionals. Supportive systems must be devised to caring for those working in ICU 
and other hospital settings, even before difficulty is evident. 
 
3. Rehearse situations of uncertainty individually and collectively: Identifying a priori 
issues health professionals anticipate as being uncertain. Reflections from clinical 
practice of situations that make health professionals feel uncomfortable e.g. type of 
patient, challenging diagnosis, system-related dilemma – what worked and why and 
what did not. Rather than being caught unaware, this appraisal offer preparation for 
future situations of uncertainty. 
 
4. Be aware of cognitive biases:  Yearning for situations of certainty amplifies the 
likelihood of cognitive biases that compromise logical reasoning. Pause and consider 
the situation, and better still discuss with colleagues.  
 
5. Uncertainty should be taught to health professionals:  Health professionals must 
challenge the cultural and educational systems set up to reward certainty, and promote a 
shift in perception of uncertainty as being negative. Medical and nursing are now 
incorporating more ‘real-life’ clinical learning, case-based approaches and training in 
health systems.  
 
Patient and family-centred uncertainties 
 
1. Patients/families as allies: Poor communication has previously been a major failing for 
those dying in hospital. Talking opening, yet sensitively, with patients with COVID-19 
and their families about their situation, rehearsing their goals of care if their situation 
worsens. Consider what they would be willing to ‘trade-off ‘to live longer, confers 
clearer information for both patients and health professionals to plan 
 
2. Help is available with difficult conversations:  The ‘Serious Illness Conversations 
Guide‘  www.ariadnelabs.org  & ‘VitalTalk’, a US-developed ‘open source’ primer: 
https://tinyurl.com/ybvqqfjt  offer excellent prompts for challenging discussions. 
 
3. Be imaginative: Since most families cannot be physically present as a consequence of 
visiting restrictions, ICU nurses are quickly finding creative ways to communicate with 
the families of patients with Covid-19, for example, video-conferencing for example 
https://tinyurl.com/ybvgr5le 
 
4. Getting ‘into the shoes’ of the patient/family: The greatest security for a highly 
anxious patient (and their family) will be hearing that regardless of the situation of 
uncertainty health professionals will not abandon them. This involves empathy or (i) 
‘seeing the world as the patient sees it’; (ii) ‘understanding the patient’s current 
feelings’; (iii) ‘being non-judgmental’ and (iv) ‘communicating that one understands’  
 
